Featured article: Current understanding of the molecular mechanisms in Parkinson's disease
This review provides basic conceptual information on the molecular mechanisms underlying Parkinson’s Disease, which may assist in the design of more effective drugs or other treatment strategies.
Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China
For new submissions from 1st January 2019, authors will need to pay an article publishing charge (APC) of £1690.00/$2400.00/€2040.00 for each article submitted and accepted for publication in the journal.
Aims and Scope
Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.
2017 Journal Metrics
48 days to first decision for reviewed manuscripts only
46.5 days to first decision for all manuscripts
96.4 days from submission to acceptance
11.9 days from acceptance to publication
115 Altmetric mentions